A particular type of anemia in humans, called β-thalassemia, results from a severe reduction or absence of a normal β chain of hemoglobin. A variety of studies have explored the use of 5-azacytidine for the treatment of such patients. How might administration of 5-azacytidine be an effective treatment for β-thalassemia? Would you consider adverse side-effects likely? Why?
We need at least 10 more requests to produce the solution.
0 / 10 have requested this problem solution
The more requests, the faster the answer.